Table of Contents
Table of Contents
Preface
Chapter One
Progressive Multifocal Leukoencephalopathy: Current Concepts of a Renewed Disease
(Inês Correia, Lívia Sousa, Neurology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal)
Chapter Two
Pathologic Features of Progressive Multifocal Leukoencephalopathy
(Erika E. Doxtader, Richard A. Prayson, Department of Pathology
Cleveland Clinic, Cleveland, OH, USA)
Chapter Three
Risk Factors and Treatment of Progressive Multifocal Leukoencephalopathy
(David Pérez-Callejo, Isabel Curto and Mariano Provencio, Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain)
Chapter Four
Progressive Multifocal Leukoencephalopathy: Risk Factors Related to Drugs and Management Strategies
(Ana Fernández Pérez, Santiago Piñeiro Conde, Pharmacy Service, University Hospital Lucus Augusti, Lugo, Spain)
Chapter Five
Risk of Immune Reconstitution Inflammatory Syndrome (IRIS) in Natalizumab-Associated PML
(Alberto Calvi, Milena Alessandra De Riz, Anna Pietroboni, Daniela Galimberti, Elio Scarpini, Neurology Unit, Dept. of Pathophysiology and Transplantation, University of Milan, Fondazione Ca’ Granda, IRCCS Ospedale Policlinico, Milan, Italy)
Index